Quantcast

Latest Interstitial lung disease Stories

2011-07-12 14:00:00

Landmark Legislation Will Coordinate and Expand National Research on Pulmonary Fibrosis CHICAGO, July 12, 2011 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) announced today the re-introduction of the Pulmonary Fibrosis Research Enhancement Act (PFREA). Bi-partisan Lead Sponsors, Senators Christopher Coons (D-DE), Mark Kirk (R-IL), Michael Crapo (R-ID), and Patty Murray (D-WA) and Representatives Erik Paulson (R, MN-3) and Tammy Baldwin (D, WI-2) made the announcement...

2011-07-07 16:59:00

BRISBANE, Calif., July 7, 2011 /PRNewswire/ -- InterMune (NASDAQ: ITMN) today announced that patient enrollment has begun in ASCEND, a new Phase 3 study of pirfenidone for patients who suffer from idiopathic pulmonary fibrosis (IPF). ASCEND is a multinational, randomized, double-blind, placebo controlled Phase 3 trial designed to evaluate the safety and efficacy of Esbriet® (pirfenidone) in IPF patients with mild to moderate impairment in lung function. The primary...

2011-07-05 10:00:00

PF Week Set for Sept. 18-24 CULVER CITY, Calif., July 5, 2011 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) announced today it has set its 2011 National Pulmonary Fibrosis (PF) Awareness Week for September 18-24, 2011. The primary goals of this year's activity are to support the Pulmonary Fibrosis Research Enhancement Act (PFREA) that will soon be introduced and to raise awareness of PF issues to Members of Congress and in communities nationwide, while...

2011-07-02 02:49:20

    * Patients with a form of pulmonary fibrosis often do not get referred to a tertiary care center quickly.     * Delayed access is associated with a higher death rate.     * Better methods of early detection would shorten time from first symptoms to referral. Idiopathic pulmonary fibrosis (IPF)"•scarring and thickening of the lungs from unknown causes"•is the predominant condition leading to lung transplantation nationwide. Columbia...

2011-06-29 12:00:00

Guy Junker and Stan Savran to Help Launch the First Violet Rippy 5K Walk/Run for the Coalition for Pulmonary Fibrosis PITTSBURGH, June 29, 2011 /PRNewswire-USNewswire/ -- Former SPORTSBEAT Co-Hosts Guy Junker and Stan Savran will reunite to host the first Violet Rippy 5K Walk/Run for Pulmonary Fibrosis. The event will be held at the North Shore Riverfront Park in Pittsburgh on Saturday, August 13, 2011 and will benefit the Coalition for Pulmonary Fibrosis (CPF). Junker and Savran, both...

2011-06-29 06:59:24

(Ivanhoe Newswire) "“ Idiopathic pulmonary fibrosis (IPF) affects about 100,000 people in the U.S. each year and is fatal within three years of diagnosis. An invasive cell that leads to lung fibrosis may be stopped by cutting off its supply of sugar, according to this study. IPF has only one therapy in the U. S.: lung transplantation. Duke researchers have found a possible new treatment by identifying a cell surface receptor on the invasive cells called myofibroblasts and an enzyme that...

2011-06-27 15:09:52

An invasive cell that leads to fibrosis of the lungs may be stopped by cutting off its supply of sugar, according to researchers at Duke University Medical Center. Idiopathic pulmonary fibrosis (IPF), which affects about 100,000 people in the U.S. each year and leads to death within three years of diagnosis, has only one therapy in the U. S.: lung transplantation. Duke researchers have found a possible new treatment by identifying a cell surface receptor on the invasive cells called...

2011-05-25 15:00:00

BRISBANE, Calif., May 25, 2011 /PRNewswire/ -- InterMune (NASDAQ: ITMN) will outline the company's corporate strategy and vision for 2015, including an update on its ongoing plans to commercialize Esbriet(®) (pirfenidone) in Europe, as well as details on ASCEND, a new Phase 3 pirfenidone study, during a meeting with analysts in New York tomorrow, May 26. InterMune will conduct a live webcast of the presentations beginning at 8:30 a.m. EDT. Dan Welch, chairman, CEO and...

2011-05-19 16:07:00

BRISBANE, Calif., May 19, 2011 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) will conduct a live webcast of its 2011 Analyst Day presentations on Thursday, May 26, 2011, from 8:30 a.m. - 11:30 a.m. EDT in New York. Presentations by InterMune's executive management team will provide an overview of the company's vision, strategy and a comprehensive update of InterMune's commercial and scientific plans. The company also will provide details on its preparations to launch...

2011-05-18 13:51:35

A Wednesday morning session will explore the inhalational exposures and respiratory outcomes of military deployment to Iraq and Afghanistan. Presenters will review current knowledge on complex inhalational exposures, epidemiologic studies, animal toxicology studies, and clinical lung findings in U.S. military men and women who are returning from Southwest Asia. D6 "Occupational Lung Diseases in U.S. Military Personnel Deployed to Iraq and Afghanistan" will take place from 8:15 to 10:45 a.m....


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related